FDA Inspection 1204111 — Hermann Haller, MD

Hermann Haller, MD — FEI 3025548494

The FDA completed an inspection of Hermann Haller, MD on March 17, 2023 in Hanover. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hanover (Germany)

Additional Details

Clinical Investigator (CI)